Highly Diverse Hepatitis C Strains Detected in Sub‐Saharan Africa Have Unknown Susceptibility to Direct‐Acting Antiviral Treatments

The global plan to eradicate hepatitis C virus (HCV) led by the World Health Organization outlines the use of highly effective direct‐acting antiviral drugs (DAAs) to achieve elimination by 2030. Identifying individuals with active disease and investigation of the breadth of diversity of the virus i...

Descripción completa

Detalles Bibliográficos
Autores principales: Davis, Chris, Mgomella, George S., da Silva Filipe, Ana, Frost, Eric H., Giroux, Genevieve, Hughes, Joseph, Hogan, Catherine, Kaleebu, Pontiano, Asiki, Gershim, McLauchlan, John, Niebel, Marc, Ocama, Ponsiano, Pomila, Cristina, Pybus, Oliver G., Pépin, Jacques, Simmonds, Peter, Singer, Joshua B., Sreenu, Vattipally B., Wekesa, Clara, Young, Elizabeth H., Murphy, Donald G., Sandhu, Manj, Thomson, Emma C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6492010/
https://www.ncbi.nlm.nih.gov/pubmed/30387174
http://dx.doi.org/10.1002/hep.30342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6492010/
https://www.ncbi.nlm.nih.gov/pubmed/30387174
http://dx.doi.org/10.1002/hep.30342

Ejemplares similares